Dr. De Santis on the Future Treatment Landscape for Bladder Cancer

Maria De Santis, MD, associate clinical professor at the University of Warwick, discusses the future treatment landscape for patients with bladder cancer.

In the future, we should differentiate between surgery, radiotherapy, and medical oncology, states De Santis.

There has been an improvement in overall survival in the second-line treatment compared to chemotherapy, and this field will expand further with new studies evaluating combinations of immunotherapy and combinations of chemotherapy with immunotherapy, as well.